510(k) device
Hemoglobin A1c Assay, Hemoglobin A1c Calibrators, Hemoglobin A1c Controls
Abbott Laboratories · Hemoglobin A1c Test System (PDJ, Class II) · First FDA decision Feb 28, 2014, newest May 22, 2015Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
143
Naming "Hemoglobin A1c"
MAUDE reports
104
Brand "Hemoglobin A1c", since 2015
PubMed studies
17,591
Mentioning "Hemoglobin A1c"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Hemoglobin A1c Assay, Hemoglobin A1c Calibrators, Hemoglobin A1c Controls
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K140654 · Decided May 22, 2015 · 434 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
K130255 · Decided Feb 28, 2014 · 392 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Glycated Hemoglobin/Glycated ProteinNational determinationOn the books190.21Updated Oct 1, 2026
- Glycated Hemoglobin/Glycated Protein (Addition of ICD-9-CM 271.3, Intestinal disaccharidase deficiencies and disaccharide malabsorption)Coding analysisReview closedCAG-00336NUpdated Sep 14, 2026
- Glycated Hemoglobin/Glycated Protein (Addition of CPT Code 83037, Hemoglobin; glycosylated [A1c] by device cleared by FDA for home use)Coding analysisReview closedCAG-00373NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Hemoglobin A1c", any status and sponsor, newest update first.
- Nudge-Based Shared Decision Making and Self-Management in Type 2 Diabetes: A Randomized TrialPivotal-lookingCompleted
Yunxuan LiAcademic, hospital or other
NCT07129915 · 280 participants · Start Nov 1, 2025 · Primary completion Oct 17, 2026
Device: Medication Preference App · For: Diabetes Mellitus, Type 2; Physician-Patient Relations; Self-management
Sites: Xiamen, China
- Trial of CGM Technology in Persons Living With PrediabetesPivotal-lookingNot yet recruiting
Wake Forest University Health SciencesAcademic, hospital or other
NCT07639593 · 100 participants (planned) · Start Apr 2027 · Primary completion Nov 2027
Device: Stelo CGM · For: Prediabetes
Sites: Winston-Salem, North Carolina
Ohio State UniversityAcademic, hospital or other
NCT06184373 · 20 participants (planned) · Start Jun 6, 2025 · Primary completion May 30, 2027
Device: Continuous glucose monitor · For: Gestational Diabetes; Hyperglycemia
Sites: Columbus, Ohio
140 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Hemoglobin A1c", and for the whole product code for context.
This brand
104 reports: 103 malfunction, 1 injury, 0 death
Whole product code PDJ
218 reports: 216 malfunction, 2 injury, 0 death
Newest reports for this brand
1823260-2026-04473 · Received Oct 28, 2026 · Event dated Sep 30, 2026
Device type: Assay, Glycosylated Hemoglobin (LCP)
Device problem as coded: High Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Atellica CH Enzymatic Hemoglobin A1c (A1c_E)Malfunction
Siemens Healthcare Diagnostics, Inc.
2432235-2026-00271 · Received Oct 21, 2026 · Event dated Oct 13, 2026
Device type: Hemoglobin A1c Test System (PDJ)
Device problem as coded: High Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Atellica CH Enzymatic Hemoglobin A1c (A1c_E)Malfunction
Siemens Healthcare Diagnostics, Inc.
2432235-2026-00255 · Received Oct 9, 2026 · Event dated Jan 21, 2026
Device type: Hemoglobin A1c Test System (PDJ)
Device problem as coded: High Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- REF: 4P52-20 Hemoglobin A1c for use with Architect, IVD, CE, R1 1 x 52 mL, R2 1 x 20 mL, A1cDL 2 x 35 mLOpen, Classified
Z-1454-2022 · Started Jun 9, 2022
Reason given: There is a potential for falsely elevated Hemoglobin %A1c and Hemoglobin A1c results to be generated using the ARCHITECT and Alinity c Hemoglobin A1c assay.
Cause as FDA categorized it: Under Investigation by firm · Device type: Hemoglobin A1c Test System (PDJ)
- REF: 08P4320, Alinity c Hemoglobin Reagent Kit, IVD, CE, R1 5 x 46.0 mL, R2 5 x 18.3 mL, A1cDL 5 x 67.6 mLOpen, Classified
Z-1455-2022 · Started Jun 9, 2022
Reason given: There is a potential for falsely elevated Hemoglobin %A1c and Hemoglobin A1c results to be generated using the ARCHITECT and Alinity c Hemoglobin A1c assay.
Cause as FDA categorized it: Under Investigation by firm · Device type: Hemoglobin A1c Test System (PDJ)
Z-1688-2020 · Started May 22, 2019
Reason given: Calibrator level 2 bottle may have been manufactured incorrectly for a portion of the lot. The manufacturer observed no impact to assay performance between the HbA1c concentration range of 5.33% to 6.87%. However, outside of this range, a bias of greater than 3% may be seen with patient results. The device failure...
Cause as FDA categorized it: Under Investigation by firm · Device type: Calibrator, Secondary (JIT)
1 more recall records with a free account
Published research
The most relevant PubMed records for "Hemoglobin A1c"[tiab]. The summary above synthesizes these.
- Should Hemoglobin A1c Targets Be Re-Evaluated?
Kumar M, Thompson PD · Am J Cardiol · 2022Editorial
- Sotagliflozin Efficacy Irrespective of Hemoglobin A1c Level.
Fonarow GC, Mohebi R · J Am Coll Cardiol · 2023Editorial, Research Support, Non-U.S. Gov't
- Lack of Association Between Hemoglobin A1c and Continuous Glucose Monitor Metrics Among Individuals with Prediabetes and Normoglycemia.
Rodriguez JA, Palermo NE, Song W, et al. · Diabetes Technol Ther · 2026
- Hemoglobinopathies and Hemoglobin A1c in Diabetes Mellitus.
Klonoff DC · J Diabetes Sci Technol · 2020Editorial
- Educational Case: Diabetic nephropathy.
Gripp EW, Chan JS · Acad Pathol · 2025Case Reports
- Getting the most out of hemoglobin A1C testing.
Goldstein DE · Pediatr Diabetes · 2010Editorial, Introductory Journal Article
- Hemoglobin A1c and diagnosis of diabetes.
Ding L, Xu Y, Liu S, et al. · J Diabetes · 2018Review
- Error! Hemoglobin A1c Outside of Range.
Rodrigue BB, Lamothe S, Kemble DJ · J Appl Lab Med · 2021
- Editorial: Global excellence in natural products for endocrine disorders.
Malvezzi H, Maurya VK, Brantley E, et al. · Front Endocrinol (Lausanne) · 2023Editorial
- Association of hemoglobin A1c with the incidence of hypertension: A large prospective study.
Huang X, Qin C, Guo X, et al. · Front Endocrinol (Lausanne) · 2022Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Should Hemoglobin A1C Be Routinely Measured in Patients with CKD?
Bansal N, Shlipak MG · Clin J Am Soc Nephrol · 2015Editorial, Comment
Other devices of this type
Also filed under product code PDJ.
- Tosoh Automated Glycohemoglobin Analyzer HLC-723GR01Tosoh Bioscience, Inc. · 510(k) 2025
- ADVIA Chemistry Enzymatic Hemoglobin Ale (Alc_E) AssaySiemens Healthcare Diagnostics, Inc. · 510(k) 2021
- Afinion HbA1c Dx on Afinion 2Alere Technologies AS · 510(k) 2018
- H100Plus Hemoglobin Testing SystemShenzhen Lifotronic Technology Co., Ltd. · 510(k) 2026
- Medconn 8K Glycated Hemoglobin Test SystemShanghai Medconn Medical Technology Co., Ltd. · 510(k) 2026
- Medconn Glycated Hemoglobin Test systemShanghai Medconn Medical Technology Co., Ltd. · 510(k) 2025
- Hipro Glycosylated Hemoglobin (HbA1c) Test SystemShijiazhuang Hipro Biotechnology Co., Ltd. · 510(k) 2024
- Tina-quant Hemoglobin A1cDx Gen.3Roche Diagnostics Operations (Rdo) · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.